Clinical Trial Update: A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial assessed safety, tolerability, pharmacokinetics, histology effects, and clinical parameters of givinostat in children with Duchenne …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Givinostat (givinostat)

Snippet

Sponsor: Italfarmaco | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-06-23